Last reviewed · How we verify

NCT05358847

Treatment for Cellulite Appearance

Completed NA Last updated 18 November 2023
What this trial tests

NA trial testing Sofwave in Cellulite in 69 participants. Completed in 1 March 2023.

Timeline
21 November 2021
Primary endpoint
1 March 2023
1 March 2023

Quick facts

Lead sponsorSofwave Medical LTD
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment69
Start date21 November 2021
Primary completion1 March 2023
Estimated completion1 March 2023
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sofwave Medical LTD

Who can join

Adults 18 to 60, female only, with Cellulite. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sofwave

Trials testing the same drug.

Other recruiting trials for Cellulite

Currently open trials in the same condition.

Other Sofwave Medical LTD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing